EUVIMEDEUVIMED entdecken
Crossref

Neuropeptide Y regulates osteocyte phenotype and function through AHNAK-Smad signalling

Xiangnan Wu, Yiqiao Wang, Hang Wang, Meirui Ma, Zhichao Hao, Yuanyuan Ma iD

Journal of Molecular Endocrinology · 2023

DOI: 10.1530/jme-23-0011 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Molecular Endocrinology, 2023. Verfasst von Xiangnan Wu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Hospital of Stomatology, Guanghua School of Stomatology, Sun Yat-sen University, Guangdong Provincial Key Laboratory of Stomatology, Guangzhou, China. Hauptthemen laut MEDLINE: Neuropeptide Y, Osteocytes. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 44 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Neuropeptide Y (NPY) is a widespread hormone in the central and peripheral nervous systems that maintains body homeostasis. Central actions of hypothalamic NPY have been identified in bone metabolism. Osteocytes are the main source of NPY in bone tissue, indicating that osteocytic NPY could be a local alternative pathway for hypothalamic mediated regulation of bone and bone cells. Here, we show that osteocytic NPY induces cell viability and proliferation. Osteocyte-derived factors are also closely associated with changes in cellular NPY mRNA levels. Furthermore, osteoblast mineralization was significantly induced by conditioned medium collected from NPY-overexpressing osteocytes ( P < 0.05). Importantly, the NPY–AHNAK interaction was identified for the first time by co-immunoprecipitation, and significant inactivation of p-Smad1/5/9 was found in osteocytes with NPY or AHNAK insufficiency ( P < 0.05). The activation of p-Smad1/5/9 reversed NPY insufficiency-caused decreases in the expression of osteocytic proliferating cell nuclear antigen and osteoblast markers including osteocalcin and Runx2 ( P < 0.05); these findings showed an additional molecular mechanism by which NPY acts on cells through AHNAK-mediated Smad1/5/9 signalling. Collectively, our findings provide novel insights into the function of NPY in regulating osteocyte phenotype and function and provide new insights for further investigation into osteocytic NPY-mediated therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neuropeptide YOsteocytesBone and BonesOsteoblastsPhenotypeHumansAnimalsMice

Stichwörter der Autor:innen

AHNAKSmad signallingneuropeptide Yosteocytes

Substanzen

Neuropeptide Y

Autor:innen und Institutionen

  • Hospital of Stomatology, Guanghua School of Stomatology, Sun Yat-sen University, Guangdong Provincial Key Laboratory of Stomatology, Guangzhou, China.
  • State Key Laboratory of Oral Diseases & National Clinical Research Center for Oral Diseases, West China Hospital of Stomatology, Sichuan University, Chengdu, China.

ORCID-Profile: Yuanyuan Ma

Zitieren

APA

Wu, X., Wang, Y., Wang, H., Ma, M., Hao, Z., & Ma, Y. (2023). Neuropeptide Y regulates osteocyte phenotype and function through AHNAK-Smad signalling. Journal of Molecular Endocrinology. https://doi.org/10.1530/jme-23-0011

Vancouver

Wu X, Wang Y, Wang H, Ma M, Hao Z, Ma Y. Neuropeptide Y regulates osteocyte phenotype and function through AHNAK-Smad signalling. Journal of Molecular Endocrinology. 2023. doi:10.1530/jme-23-0011

BibTeX
@article{Wu2023,
  author = {Wu, Xiangnan and Wang, Yiqiao and Wang, Hang and Ma, Meirui and Hao, Zhichao and Ma, Yuanyuan},
  title = {Neuropeptide Y regulates osteocyte phenotype and function through AHNAK-Smad signalling},
  journal = {Journal of Molecular Endocrinology},
  year = {2023},
  doi = {10.1530/jme-23-0011}
}
Kostenlos starten →